Eugene W Liu1, Holly M Chastain1, Sun Hee Shin1, Ryan E Wiegand1, Deanna Kruszon-Moran2, Sukwan Handali1, Jeffrey L Jones1. 1. Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
Background: Toxocariasis results from infection with larval stages of a dog and cat intestinal nematode and causes human morbidity. The current United States estimate of Toxocara exposure is 13.9% (National Health and Nutrition Examination Survey [NHANES] III [1988-1994]). Methods: We used a multiplex bead-based assay (Tc-CTL-1MBA) with purified Toxocara canis antigen to estimate Toxocara antibody seroprevalence in serum of 13 509 persons aged ≥6 years from NHANES 2011-2014 and identified seropositivity risk factors. We tested a subset of 500 samples with the T. canis enzyme immunoassay used in NHANES III to estimate prior seroprevalence had samples from NHANES III been tested by Tc-CTL-1MBA. Results: The age-standardized estimate of Toxocara seroprevalence was 5.0% (95% confidence interval [CI], 4.2%-5.8%), lower than previously reported even after adjusting for increased Tc-CTL-1MBA specificity. Risk factors for seropositivity from multiple logistic regression were older age, non-Hispanic black/Hispanic origin, male sex, living below poverty level, households with ≥0.5 persons per room, less than college education, and birth outside of the United States. Conclusions: Toxocara seroprevalence estimates in 2011-2014 were lower than in a study from NHANES III (1988-1994), but seropositivity risk factors remained the same and should continue to be the focus of prevention efforts. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Toxocariasis results from infection with larval stages of a dog and cat intestinal nematode and causes human morbidity. The current United States estimate of Toxocara exposure is 13.9% (National Health and Nutrition Examination Survey [NHANES] III [1988-1994]). Methods: We used a multiplex bead-based assay (Tc-CTL-1MBA) with purified Toxocara canis antigen to estimate Toxocara antibody seroprevalence in serum of 13 509 persons aged ≥6 years from NHANES 2011-2014 and identified seropositivity risk factors. We tested a subset of 500 samples with the T. canis enzyme immunoassay used in NHANES III to estimate prior seroprevalence had samples from NHANES III been tested by Tc-CTL-1MBA. Results: The age-standardized estimate of Toxocara seroprevalence was 5.0% (95% confidence interval [CI], 4.2%-5.8%), lower than previously reported even after adjusting for increased Tc-CTL-1MBA specificity. Risk factors for seropositivity from multiple logistic regression were older age, non-Hispanic black/Hispanic origin, male sex, living below poverty level, households with ≥0.5 persons per room, less than college education, and birth outside of the United States. Conclusions: Toxocara seroprevalence estimates in 2011-2014 were lower than in a study from NHANES III (1988-1994), but seropositivity risk factors remained the same and should continue to be the focus of prevention efforts. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
Toxocara canis; Toxocara cati; United States; antibodies; seroprevalence
Authors: J Buijs; G Borsboom; J J van Gemund; A Hazebroek; P A van Dongen; F van Knapen; H J Neijens Journal: Am J Epidemiol Date: 1994-11-01 Impact factor: 4.897
Authors: John P Anderson; Lisa N Rascoe; Keith Levert; Holly M Chastain; Matthew S Reed; Hilda N Rivera; Isabel McAuliffe; Bin Zhan; Ryan E Wiegand; Peter J Hotez; Patricia P Wilkins; Jan Pohl; Sukwan Handali Journal: PLoS Negl Trop Dis Date: 2015-10-20
Authors: Kengo Inagaki; Brian Kirmse; Richard S Bradbury; Ramana S Moorthy; Irene Arguello; Charles D McGuffey; Brian Tieu; Charlotte V Hobbs Journal: Am J Trop Med Hyg Date: 2019-05 Impact factor: 2.345
Authors: Andrea Corda; Claudia Tamponi; Roberta Meloni; Antonio Varcasia; Maria Luisa Pinna Parpaglia; Pablo Gomez-Ochoa; Antonio Scala Journal: Parasitol Res Date: 2019-01-31 Impact factor: 2.289
Authors: Fakhreldin M Omer; Nabil J Awadalla; Safar Abadi Alsaleem; Mohammed Abadi Alsaleem; Riyad A Moosa; Mohamed A Alqahtani; Abdulmageed A Asiri; Ebtesam M Alahmari; Amal N Alqahtani; Ahmed A Mahfouz Journal: Ecohealth Date: 2021-05-20 Impact factor: 3.184
Authors: Richard S Bradbury; Irene Arguello; Meredith Lane; Gretchen Cooley; Sukwan Handali; Silvia D Dimitrova; Fernanda S Nascimento; Sam Jameson; Kathryn Hellmann; Michelle Tharp; Paul Byers; Susan P Montgomery; Lisa Haynie; Brian Kirmse; Nils Pilotte; Steven A Williams; Charlotte V Hobbs Journal: Am J Trop Med Hyg Date: 2020-09 Impact factor: 2.345
Authors: Jesica A Herrick; Monica Nordstrom; Patrick Maloney; Miguel Rodriguez; Kevin Naceanceno; Gloria Gallo; Rojelio Mejia; Ron Hershow Journal: Parasitol Res Date: 2020-02-01 Impact factor: 2.289